BPC 157 disappears from the blood very quickly (in less than 30 minutes) in animals, but people are selling it in 200 microgram capsules without knowing if this is safe or even reaches the bloodstream.

Evidence from Studies

No evidence studies found yet.

What Would Prove This

Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.

Randomized Controlled Trials

Pharmacokinetic profile of BPC 157 in humans after various doses and routes

Phase I dose-escalation study in 48 healthy volunteers receiving single ascending oral doses of BPC 157 (100 μg, 200 μg, 400 μg, 800 μg, 1600 μg) with intensive pharmacokinetic sampling and bioavailability assessment vs. intravenous reference

Cohort Studies

Pharmacokinetic parameters in target patient populations

Open-label pharmacokinetic study in 60 patients with inflammatory conditions receiving BPC 157 at proposed therapeutic doses with serial blood sampling

Source Study

Reply to Sikiric et al. BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide’s Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on “Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review. Pharmaceuticals 2025, 18, 185”

DOI: 10.3390/ph18101451

BPC 157 disappears from the blood very quickly (in less than 30 minutes) in animals, but people are selling it in 200 microgram capsules without knowing if this is safe or even reaches the bloodstream.

Claim Context

Evidence from Studies

What Would Prove This

Source Study